Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.
Paysign Inc. (PAYS) delivers innovative prepaid card solutions and digital payment services for healthcare, corporate, and government sectors. This news hub provides investors with essential updates on the company’s financial performance and strategic direction.
Access real-time announcements including earnings reports, partnership developments, and product innovations. Our curated collection features regulatory filings, leadership changes, and market expansion updates critical for informed decision-making.
Discover comprehensive coverage of Paysign’s fintech advancements in patient affordability programs and integrated payment processing. Content spans merger activity, technology patents, and compliance updates, maintained for accuracy and relevance.
Bookmark this page for streamlined access to Paysign’s evolving financial narrative. Combine fundamental analysis with timely news to track the company’s position in competitive payment processing markets.
Paysign, Inc. (NASDAQ: PAYS) reported its first-quarter 2021 financial results, showing a 40.6% revenue decline to $6.3 million compared to Q1 2020. Plasma revenue decreased 26.7% due to lower donations exacerbated by pandemic-related factors. Despite adding three new plasma centers, average revenue per center dropped 38.8%. For 2021, Paysign anticipates total revenue between $29.0 million and $32.0 million, with adjusted EBITDA forecasted at $0.35 million to $1.90 million. The company maintains a healthy balance sheet with $6.6 million in cash and zero debt.
Paysign, Inc. (NASDAQ: PAYS) is set to discuss its first-quarter 2021 earnings on May 11, 2021, at 5:00 p.m. Eastern Time.
The company specializes in prepaid card programs and payment processing services, targeting businesses and government institutions. Investors can join the discussion via dial-in or webcast, with a replay available until August 11, 2021.
Paysign, Inc. (NASDAQ: PAYS) has launched the Paysign Premier referral program, facilitating businesses' access to digital banking solutions for their payees. This initiative incurs no startup costs and is available immediately. The Premier digital bank account enhances payment processes, offering features like early pay access, cash back rewards, and 24/7 bilingual customer service. CEO Mark Newcomer highlighted the importance of digital banking, especially post-COVID-19, as a way for businesses to streamline payouts and provide valuable services to their payees.
Paysign, Inc. (NASDAQ: PAYS) reported financial results for Q4 and the fiscal year 2020, facing challenges due to the COVID-19 pandemic. Total revenues fell to $7.25 million in Q4, down 25.7% from $9.76 million in Q4 2019. Plasma revenue decreased by 17.5% to $6.3 million. The company incurred a net loss of $4.3 million compared to a profit of $1.9 million last year. Despite the challenges, Paysign added 55 new plasma programs and ended the year with $7.8 million in cash and no debt, positioning itself for recovery as restrictions ease.
Paysign, Inc. (NASDAQ:PAYS) will discuss its fourth quarter and full-year 2020 earnings on March 25, 2021, at 5:00 p.m. Eastern time. The company, known for prepaid card programs and payment processing services, enables digital payout solutions for various sectors, including healthcare and retail. Financial professionals wishing to ask questions during the call need to register by March 23, 2021. Replay options will be available until June 25, 2021.
Paysign, Inc. (NASDAQ:PAYS) announced significant executive changes, appointing Matthew Lanford as president and chief operating officer, and Jeffrey Baker as chief financial officer, effective February 22, 2021. Lanford, with over 30 years in the payments industry, was previously chief product officer at Paysign, while Baker brings extensive experience from InComm Payments and Global Payments. These leadership changes aim to enhance Paysign's strategic priorities and financial growth.
Paysign (NASDAQ: PAYS) and ImmunoTek Bio Centers announce the integration of COVID-19 convalescent plasma collection with a prepaid card program for donor compensation. ImmunoTek has established plasma collection from recovered COVID-19 patients at Mount Sinai to develop COVID-19 hyperimmune globulin for clinical trials. Paysign’s customized prepaid debit card program enhances donor experience, motivates donations, and streamlines payment processes. Both companies aim to support the development of critical therapies while improving donor retention and the collection process.
Paysign, Inc. (NASDAQ: PAYS) reported its third quarter 2020 financial results, showing a 32% revenue decline year-over-year, primarily due to COVID-19's impact on the pharma and plasma industries. Total revenues fell to $16.87 million, with a net loss of $4.83 million, down from a profit of $5.57 million in 2019. Operating expenses surged 39% due to staffing and professional service costs. Despite these challenges, the company remains optimistic about recovery as new client onboarding may boost revenues in the fourth quarter.
Paysign, Inc. (NASDAQ: PAYS) will discuss its 2020 Q3 earnings on November 17, 2020, at 5:00 p.m. ET. The financial results, including the Form 10-Q, will be released after market close. Investors can participate via a U.S. dial-in at 877.407.2988 or internationally at 201.389.0923. A replay of the call will be available using the conference ID 13713279.
Paysign is known for its prepaid card programs and integrated payment services across various sectors, including healthcare and retail, aimed at improving operational efficiency and customer loyalty.
